System and method for providing concentrated oxygen to a user

By adopting dual-column pressure swing adsorption technology and a variety of zeolite adsorbents in portable oxygen generators, combined with the adaptive control of sensors and processors, the existing POCs are solved, and the problems of high weight, high cost and limited oxygen output are achieved. Lightweight, efficient oxygen output and flexible oxygen therapy.

CN112105409BActive Publication Date: 2024-12-03LLM TECH AUSTRALIA PTY LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN201980027221.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2018-04-20
Filing Date
2019-04-12
Publication Date
2024-12-03
Estimated Expiration
2039-04-12

AI Technical Summary

Technical Problem

The existing portable oxygen generator (POC) is large in weight and high in cost, and the oxygen output is manually controlled, the oxygen purity and dose capacity are limited, and the adsorbent utilization rate is low, which cannot meet the oxygen demand of different active levels, resulting in excessive or insufficient oxygen. question.

Method used

A portable oxygen generator is designed, using dual-column pressure-switching adsorption (PSA) technology, using a variety of zeolites as adsorbents, combining sensors and processors to adjust the oxygen output in real time according to the user's physiological parameters, including top and bottom disparities. Tubes, solenoid valves and wave springs for adaptive oxygen titration and automated control.

Benefits of technology

It realizes lightweight and efficient oxygen output, and can adjust oxygen flow in real time according to the user's activity level, improve oxygen purity and utilization, reduce the risk of excessive or insufficient oxygen, and enhance the flexibility and safety of oxygen treatment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112105409B_ABST
    Figure CN112105409B_ABST
Patent Text Reader

Abstract

An embodiment of the present invention provides a portable oxygen concentrator. The portable oxygen concentrator may include an input, an input filter, a compressor, a first column, and a second column, wherein the input is configured to receive an airflow; the compressor is configured to compress the airflow; the first column includes a first adsorbent bed; the second column is adjacent to the first column and includes a second adsorbent bed. The portable oxygen concentrator may further include a first output and a second output, wherein the first output is configured to release oxygen to a user; the second output is configured to release exhaust gas. The first and second adsorbent beds may include a plurality of zeolites.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Cross-application of related patent applications

[0002] This application claims priority under 35 U.S.C. 119 to U.S. Provisional Patent Application No. 62 / 660,421, filed on April 20, 2018, the disclosure of which is incorporated herein by reference in its entirety. Background Art

[0003] Existing oxygen delivery systems on the market today are heavy, costly, require ongoing maintenance, and contain convenient, easy-to-use dials and switches that allow the user to change the flow rate setting. In addition, current technology is limited in maximum dosing capabilities and oxygen purity levels. Moreover, portable oxygen concentrators (POCs) currently on the market provide manual control of oxygen output. Therefore, after a doctor prescribes a prescription, the patient can select a preset output in liters per minute (LPM), typically 1 to 5 LPM. Typically, as prescribed, the patient will set a lower LPM setting when idle or resting, and a higher LPM when anticipating strenuous activity.

[0004] Current medical devices are also narrowly focused on providing a single, “static” solution focused on treating a linear disease. Unfortunately, diseases and the treatments they require are not always limited to one discipline or organ. Likewise, if doctors do not communicate a condition, it can lead to duplicate tests, wasted time, and lost money.

[0005] In addition, although current POCs use adsorbent beds, such as zeolite beds, the utilization rate is around 25%. Therefore, when the mass transfer zone (MTZ) reaches the end of the zeolite bed, the zeolite adsorption performance becomes ineffective. Therefore, it is necessary to improve the POC to reduce the MTZ so that the MTZ stays in the zeolite bed longer, thereby allowing more zeolite to adsorb.

[0006] Embodiments of the present invention provide a portable oxygen concentrator (POC) that is specifically designed to meet patient and physician needs and desired goals for corrected dose volume and oxygen purity to meet the needs of patients at any activity level.

[0007] The increase in the longevity of the population and the need to improve the quality of life are driving the healthcare industry. Conditions such as hypoxemia (not enough oxygen in the blood), especially chronic obstructive pulmonary disease (COPD), asthma, pneumonia, heart failure, major trauma and obstetric emergencies require an effective oxygen delivery system that integrates with the user's lifestyle.

[0008] The foundations supporting this trend include the following megatrends:

[0009] ·Increase in longevity

[0010] The need to improve quality of life and the need for medical devices to be flexible, “smart” and adapt to the needs of the user

[0011] Medical devices are required to have analytical capabilities to assist clinicians and patients in monitoring their conditions while carrying out a variety of normal daily activities.

[0012] Increased air pollution leads to increased aerobic healthcare

[0013] · Need for simplified, lightweight technology

[0014] Greater focus on performance and efficiency Summary of the invention

[0015] According to an exemplary embodiment of the present invention, a portable oxygen concentrator is provided. The portable oxygen concentrator may include an input, an input filter, a compressor, a first column, a second column, a first output, and a second output, wherein the input is configured to receive a gas flow; the compressor is configured to compress the gas flow; the first column includes a first adsorbent bed; the second column is adjacent to the first column; the first output is configured to release oxygen to a user, and the second output is configured to release exhaust gas. The second column may include a second adsorbent bed. The first and second adsorbent beds may each contain a plurality of zeolites.

[0016] In another embodiment, the portable oxygen concentrator may further include a top manifold at the distal ends of the first and second columns and a bottom manifold at the proximal ends of the first and second columns. The top and bottom manifolds may include the first and second outputs and an internal tube network configured to allow airflow. In other aspects, the top and bottom manifolds may further include a plurality of solenoid valves configured to control air flow. In yet another embodiment, the top and bottom manifolds may further include a plurality of holes configured to control air flow rate. The top and bottom manifolds may be made of various materials, including metal alloys or polymer materials, such as plastics or resins. The top and bottom manifolds may be manufactured by injection molding, computer numerical control (CNC) or 3D printing (additive manufacturing).

[0017] According to another embodiment, the first diameter of the input of the portable oxygen concentrator can be greater than the second diameter of the second output. In other aspects, the top and bottom manifolds can include a plurality of check valves configured to seal the plurality of apertures.

[0018] The first and second columns of the portable oxygen concentrator may include at least one of aluminum or a thermoplastic material. In other aspects, the shapes of the first and second columns may vary. For example, the shapes of the first and second columns may be cylindrical, rectangular, or triangular. In some embodiments, the first and second columns may be 3D printed. In another embodiment, the proximal ends of the first and second columns may be connected to the first output, and the distal ends of the first and second columns may be connected to the compressor. The first column and the second column may each include an O-ring connected to at least one of the proximal end or the distal end.

[0019] In other embodiments, the portable oxygen concentrator may further include a cover or cap at the proximal and distal ends of the first and second columns. The cover or the cap may include a tapered airflow path. In another embodiment, the portable oxygen concentrator may include at least one sintered glass filter disc at the proximal and distal ends of the first and second columns. The sintered glass filter disc may be configured to filter the plurality of zeolites from the compressed air. In other embodiments, the portable oxygen concentrator may further include a wave spring located between the cover and the at least one sintered glass filter disc. The wave spring may be configured to compress the plurality of zeolites in the first and second columns. Alternatively, the portable oxygen concentrator may include a dense foam material located in the cover. The dense foam material may be configured to compress the plurality of zeolites in the first and second columns. In yet another embodiment, the portable oxygen concentrator may include a rubber durometer located in the cover. The rubber durometer may be configured to compress the plurality of zeolites in the first and second columns.

[0020] In another embodiment, the portable oxygen concentrator may further include at least one sensor and a processor. The sensor may be configured to detect at least one physiological parameter of the user. The processor may be configured to adjust the amount of oxygen released to the user according to the detected at least one physiological parameter. In some embodiments, the sensor may include at least one of a pulse oximeter, a differential pressure sensor, an ECG, an EEG, a gyroscope, an accelerometer, or any combination thereof. The detected user physiological parameter may include at least one of a respiratory volume, an exhaled CO2 air concentration, an SpO2 concentration, a heart rate, a pulse rate, an average number of breaths per minute, an inspiratory pressure, an expiratory pressure, a breathing sound, or any combination thereof. In some embodiments, the portable oxygen concentrator may include a printed circuit board (PCB) connected to a compressor, and at least one sensor may be connected to the PCB. In other embodiments, the processor may be configured to generate an alarm when the detected at least one physiological parameter is above or below a predetermined threshold.

[0021] According to an embodiment of the present invention, the plurality of zeolites may include at least one of LiLSX zeolite, LiAgX zeolite, AgX zeolite, NaX zeolite, or CaA zeolite. For example, the plurality of zeolites may include at least one activated alumina composition and a LiLSX composition. In some embodiments, the activated alumina composition may include at least one of Al2O3, Na2O, Fe2O3, TiO2, or SiO2. In other embodiments, the LiLSX composition may include at least one of zeolite, cubic, crystalline, synthetic, fiber-free, mineral binder, or quartz (SiO2).

[0022] According to another embodiment, when the second column is configured to release exhaust gas to the second output, the first column of the portable oxygen concentrator may be configured to provide oxygen to the first output. When the second column is configured to provide oxygen to the first output, the first column may be further configured to release exhaust gas to the second output. In other embodiments, the ratio of the diameter to the length of the first and second columns is about 1:6. In other aspects, the first and second columns may each contain about 20 to about 80 grams of zeolite. In some embodiments, the pressure within the first and second columns may be maintained between about 1 bar pressure and about 5 bar pressure. For example, the pressure within the first and second columns may be maintained between about 1.25 bar pressure and about 2 bar pressure. In some embodiments, the first and second columns may be configured to allow radial flow of air, thereby passing the air through the first and second columns and increasing contact with the multiple zeolites in the first and second adsorbent beds.

[0023] The portable oxygen concentrator may further include a user interface configured to receive user input. The processor may be configured to adjust the amount of oxygen released to the user based on the received user input. In other embodiments, the portable oxygen concentrator may include a wireless receiver configured to receive data from a remote device. The processor may be configured to adjust the amount of oxygen released to the user based on the received data. The remote device may include at least one of a computer, a smartphone, a wearable device, or any combination thereof. In some embodiments, the portable oxygen concentrator may further include a removable battery connected to the first and second columns.

[0024] According to another embodiment of the present invention, a method of providing concentrated oxygen to a user is provided. The method may include directing and compressing air to a first column of an oxygen concentrator. The first column may include a first adsorbent bed. The method may further include absorbing nitrogen and oxygen molecules from the air in the first adsorbent bed and directing and compressing the air to a second column of the oxygen concentrator adjacent to the first column. The second column may include a second adsorbent bed. The method may further include absorbing nitrogen and oxygen molecules from the air in the second adsorbent bed and depressurizing the first column. Depressurizing the first column may cause argon and nitrogen molecules in the first column to be purged from the oxygen concentrator and released into the atmosphere. The method may further include directing and compressing the air to the first column and depressurizing the second column. Depressurizing the second column may cause argon and nitrogen molecules in the second column to be purged from the oxygen concentrator and released into the atmosphere. In some embodiments, depressurizing the first column and directing and compressing the air to the second column may be performed simultaneously.

[0025] According to another embodiment of the present invention, a zeolite composition for providing concentrated oxygen to a user is provided. The zeolite composition may include an activated alumina composition and a LiLSX composition. The weight ratio of the activated alumina composition to the LiLSX composition may be in the range of about 0.2 to about 0.5. In some aspects, the LiLSX composition may include a plurality of first particles. The first particles may each have a size of about 0.4 mm and a mesh size of about 30x60. In other aspects, the activated alumina composition may include a plurality of second particles. The second particles may each have a size of about 0.5 mm and a mesh size of about 28x48. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 Various components of an exemplary oxygen supply system according to an embodiment of the present invention are shown.

[0027] Figures 2A-2D The steps of pressure swing adsorption (PSA) in a double column system according to an embodiment of the present invention are shown.

[0028] Figure 3 is a partial perspective view of an exemplary device according to an embodiment of the present invention.

[0029] Figure 4 is a partial perspective view of a top manifold design of an exemplary apparatus according to an embodiment of the present invention.

[0030] Figure 5 is a partial perspective view of a bottom manifold design of an exemplary apparatus according to an embodiment of the present invention.

[0031] Figures 6A-6D The steps of pressure swing adsorption (PSA) in a double column system according to an embodiment of the present invention are shown.

[0032] Figures 7A-7E The steps of pressure swing adsorption (PSA) in a double column system according to an embodiment of the present invention are shown.

[0033] Figures 8A-8D The steps of pressure swing adsorption (PSA) in a double column system according to an embodiment of the present invention are shown.

[0034] Figures 9A-9E The steps of pressure swing adsorption (PSA) in a double column system according to an embodiment of the present invention are shown.

[0035] Fig.10 is a partial perspective view of a dual-column system of an exemplary apparatus according to an embodiment of the present invention.

[0036] Fig.11A The pulse flow of oxygen delivered by current portable oxygen concentrator (POC) devices is graphically illustrated.

[0037] Fig. 11B A continuous flow of oxygen delivered by an exemplary device according to an embodiment of the present invention is graphically illustrated.

[0038] Fig.12 A container / column is shown for an exemplary device according to an embodiment of the present invention.

[0039] Fig.13 A cross-sectional view of an exemplary device according to an embodiment of the present invention is shown.

[0040] Fig.14 A wave spring of an exemplary apparatus according to an embodiment of the present invention is shown.

[0041] Fig.15 A cross-sectional view of a column of an exemplary device according to an embodiment of the present invention is shown.

[0042] Fig.16 is an exemplary electronic circuit diagram for implementing PSA system automation according to an embodiment of the present invention.

[0043] Fig.17 The steps of pressure swing adsorption (PSA) in a double column system according to an embodiment of the present invention are shown.

[0044] Fig.18 The weight specific loading of the zeolite and the pressure on the zeolite bed are compared graphically. DETAILED DESCRIPTION

[0045] Embodiments of the present invention are directed to an adaptive oxygen concentrator device. Specifically, embodiments of the present invention are directed to an intelligent oxygen concentrator paired with real-time oxygen titration. The intelligent oxygen concentrator device can detect and predict when a user or patient is idle or performing activities that require increased or decreased oxygen supply. When these changes in status are detected, the device will be able to automatically change the oxygen output settings to provide the patient with adequate oxygen. In other embodiments, the device can adjust and actually change the oxygen dosage based on the patient's different activity levels. It is the first truly new design integrated oxygen device.

[0046] Just as importantly, the device is able to reduce the oxygen delivered to the patient. As mentioned previously, especially for moderate / severe COPD patients where the target SpO2 should be 88-92%, overdosing these patients with oxygen can have adverse effects on their health, with the potential risk of hypercapnic respiratory failure, which essentially means their respiratory system shuts down due to too much oxygen being delivered (i.e. SpO2 of 92-96%).

[0047] According to embodiments of the present invention, the device can provide medical equivalent concentrated oxygen with customized actionable information and is smaller and lighter than existing devices on the market.

[0048] The device of the present invention can provide a true harmony of digital healthcare and health hardware. The device of the present invention can revolutionize the oxygen industry which has not seen innovation for over 10 years, making it the first adaptive device for personalized health, the smallest and lightest device on the market designed and manufactured for the world.

[0049] Currently available portable oxygen concentrators (POCs) do not have the following features:

[0050] Use and record important clinical data; and

[0051] Change, adjust and vary oxygen delivery based on the user's activity level.

[0052] Our initial research revealed insights from respiratory physicians and users. Based on their professional experience using POCs for oxygen therapy, specifically supplemental oxygen, the following points were noted:

[0053] Pulse flow on many POCs indicates that they can produce a certain amount of LPM continuously when in fact they are run at pulse flow; if there is any increase in activity or breathing rate, the POC often struggles to produce the required amount of oxygen for the user.

[0054] As breathing rate and volume demands increase, neither oxygenation nor waste gas recirculation purification can keep up with the increased demand and therefore cannot produce the required LPM of oxygen for the user.

[0055] The device of the present invention comprises an adaptive oxygen concentrator device that is responsive to the breathing needs of the user. The device is expected to "intelligently" adjust, change and adapt to the needs of the user by virtue of its proprietary algorithm without the need for manual input adjustments. To date, there are no portable adaptive oxygen devices with this capability to prevent overdosage and / or underdosage of oxygen. The device of the present invention can be purposefully designed and manufactured to ensure that it meets the needs of a wide range of individuals using the device.

[0056] Clinicians are reluctant to allow patients to adjust their own oxygen therapy. The key recommendations from the Australian and New Zealand Thoracic Society are as follows:

[0057] In patients with COPD and other conditions associated with chronic respiratory failure, oxygen should be given if the blood oxygen saturation (SpO2) is less than 88% and the target SpO2 range is 88% to 92%.

[0058] In other acute medical conditions, oxygen should be given if SpO2 is less than 92% and the target SpO2 range is 92% to 96%.

[0059] The ability to tailor oxygen flow to the patient's needs is required in order to:

[0060] Minimize episodes of low blood oxygen concentration (desaturation)

[0061] Avoid excessive oxygen administration, which may cause respiratory acidosis

[0062] Customize oxygen flow to patient needs, especially during activity and sleep.

[0063] The benefits of automated oxygen titration also include increased patient safety, reduced desaturation time, and reduced potential for hyperoxia. A Canadian study used an automated closed-loop oxygen delivery system that has the potential to optimize oxygen titration and reduce complications associated with oxygen therapy. Controllers can be placed to regulate oxygen flow by providing continuous monitoring within a closed-loop system with the primary parameter SpO2, with the goal of maintaining a predefined SpO2 target, which can significantly improve patient safety and physician and nurse compliance with corrective oxygen administration.

[0064] Additionally, in some countries such as Australia, home oxygen prescriptions will need to detail the user’s oxygen dosage level. This level of detail will require oxygen equipment to be able to work across a range of lifestyles and activity levels. Throughout the progression of the disease, a user’s oxygen requirements may increase and / or decrease. The flexibility of the device to change and adapt to these requirements is likely to improve the quality of health for the user.

[0065] To date, current technology has been limited in its dosing capabilities and oxygen purity, but the added ability to monitor blood oxygen saturation levels in real time will be integral to personal health. The data collected becomes vital to physicians looking to improve the user’s overall health and quality of life.

[0066] Embodiments of the present invention provide an adaptive device that increases portability and customizes its algorithms to provide substantial benefits, including, for example:

[0067] 1) Reduce the risks associated with desaturation while improving overall better clinical outcomes.

[0068] 2) Correct oxygen intake by combining traditional oxygen prescription with the user's activity level

[0069] 3) Provide physicians with more data, revealing insights and patterns not typically captured by arterial blood gases (ABGs).

[0070] The device of the present invention provides a compelling ecosystem paired with real-time oxygen titration, allowing critical feedback data between the user, clinician and the device, which is not currently seen in devices available on the market.

[0071] like Figure 1 As shown, a portable oxygen concentrator (POC) can store the user's health diagnosis. Practitioners and clinicians, such as Figure 1 In another embodiment, the POC can be connected to a variety of remote devices, including smartphones, computers, tablets, smart bracelets or other wearable devices. The POC can be connected to other remote devices wirelessly or via cables (such as USB data cables).

[0072] The POC may include a user interface configured to receive user input. The user input may be used to adjust the amount of oxygen released to the user. In some embodiments, the POC may include a wireless receiver to receive data from various remote devices. The remote device may include, but is not limited to, a computer, a smartphone, or a wearable device.

[0073] The human body requires a constant and continuous supply of oxygen. Depending on your activity, your muscles will work harder during periods of increased activity, which means their demand for oxygen increases. This is because oxygen is needed to burn calories more efficiently. Since the blood picks up oxygen in the lungs, and the demand for oxygen increases during exercise, the lungs have to work harder. By increasing the breathing rate, more oxygen is taken up in the lungs to be delivered to the working muscles.

[0074] The body uses oxygen to produce energy, and this oxygen is supplied through your bloodstream. This results in a direct, positive relationship between your heart, breathing, and physical activity rates. However, your physical activity rate can exceed your maximum heart rate and breathing rate. This results in short periods where oxygen is not used to produce energy. By combining aerobic and anaerobic activity, you can greatly improve your strength, endurance, training gains, and cardiorespiratory fitness.

[0075] Heart rate or pulse is the number of times your heart beats in one minute. A normal resting pulse ranges from 60 to 100 beats per minute, depending on your age and fitness level. Your breathing rate is measured in a similar way, with an average resting rate of 12 to 20 breaths per minute. With exercise, both your pulse and breathing rate increase, to about 1 breath for every 4 heartbeats.

[0076] Lung disease (also known as chronic obstructive pulmonary disease (COPD) or impairment of lung function during breathing means that more oxygen may be needed to meet the body's oxygen needs. At sea level, normal oxygen levels are thought to be between 95-97%. The need for more oxygen depends on the level of oxygen in the bloodstream during rest, physical exertion and sleep. Oxygen levels below 90% indicate a need for supplemental oxygen so that the individual can carry out daily activities. Oxygen should be given in a way that minimizes the likelihood of hyperoxia (excess oxygen in the lungs or other body tissues) or hypoxemia (abnormally low oxygen in the blood). An oximeter (or smart bracelet) is used to show how much oxygen a person's blood is filled with. An SpO2 (blood oxygen saturation) oximeter reading can be used as a guide to how much oxygen is in the blood and how much more oxygen is needed.

[0077] The device of the present invention connects these key physiological relationships together to create an adaptive algorithm that can recognize a range of user activity levels and optimize oxygen flow to meet the needs of the user. Embodiments of the present invention provide a complete integrated system that can combine auxiliary electronics, adsorbents, and sensors designed for more efficient oxygen concentration. Adsorbents can be used in conjunction with the system to concentrate ambient oxygen and produce the desired oxygen levels. Multiple adsorbents can be used in a staged process to purify ambient air and increase oxygen purity output to reduce the volume of adsorbents (such as zeolites) required, thereby reducing the size of the device. In some embodiments, specific percentages of different adsorbents (such as zeolites) can be used in different layers to achieve the medical equivalent of concentrated oxygen. In some embodiments, the system can utilize sensor data, formulas, and / or adaptive algorithms to adjust and change oxygen output nearly instantaneously using readily available data. The type of sensor required to drive the automation side may be associated with adaptive oxygen titration. In other embodiments, the system can determine the oxygen saturation range required to output the correct amount of oxygen LPM. In some embodiments, the system can accurately read an individual's oxygen needs based on a digital adaptive algorithm that includes a series of primary (e.g., oxygen saturation) and secondary (e.g., breaths per minute, heart rate, respiratory rate) data readings of the user. The system can be used to minimize excess or deficiency of oxygen. In some embodiments, data from the portable oxygen concentrator can be sent to a smartphone application to generate reports and allow the application to interact with the portable oxygen concentrator. The system can provide continuous oxygen flow and / or pulse flow and can include a controller to monitor oxygen and pressure output.

[0078] Pressure Spring Adsorption (PSA)

[0079] Pressure spring adsorption (PSA) is a common gas separation method in chemical production plants, which is simple and cost-effective compared to other medium- and large-scale separation methods. PSA is unique compared to other processes because most other industrial separation processes operate at a steady state, the PSA process is dynamic because the conditions within the column are constantly changing. Eventually, the method may need to be scaled down to produce portable oxygen concentrators (POCs) because it has great potential in mobility. The process operates in a cycle where the column repeatedly undergoes a series of pressurization, adsorption, and regeneration steps.

[0080] Oxygen (O2) is used in various chemical processes and for medical purposes throughout the world. Current methods of enrichment are:

[0081] Cryogenic distillation: This is the leading process for mass production of 99% oxygen. However, the process requires extensive equipment, can be hazardous, and is inefficient.

[0082] Membrane separation: Suitable for medium and large-scale production. However, this process requires a large surface area, requires a large compressor, and has safety risks.

[0083] Pressure Swing Adsorption (PSA): Separates molecules using adsorbents (zeolites, nanotubes) in two adsorption columns. The most common process uses two columns. However, in commercial industry, it will have four or more column systems. With the commercialization of advanced adsorbents such as zeolites, PSA has become an important alternative to cryogenic distillation and membrane separation processes to concentrate O2 from air.

[0084] The PSA process uses a column filled with adsorbent where the feed mixture is introduced at one end of the column and the product is discharged from the other end. The feed gas concentration changes over time within the column and a concentration wave is formed within the column as the adsorbate passes from the liquid phase into the adsorbed phase. This occurs in the mass transfer zone (MTZ) which travels through the column and eventually reaches the other end of the column. This results in what is known as a breakthrough curve, which occurs when the outlet concentration of the adsorbate starts to increase and eventually reaches the inlet adsorbate concentration. The shape of this breakthrough curve depends largely on the shape of the adsorption isotherm that exists between the adsorbent and the adsorbate and whether the equilibrium is favorable or unfavorable for adsorption.

[0085] The basic premise of PSA is that one or more columns are filled with an adsorbent (zeolite, carbon molecular sieve, etc.) that preferentially adsorbs gas molecules that are not in the gas mixture passing through the column. This usually occurs at a certain pressure above atmospheric pressure until the gas has nearly saturated the column with the more strongly adsorbed gas molecules.

[0086] The product is the less adsorbed type of gas molecule and is discharged from the product end of the column. In order to reuse the column later in the process, the unwanted components need to be removed from the column by desorption or regeneration. Desorption of the column is critical to the PSA process.

[0087] Desorption in the PSA process is performed by changing the pressure and composition of the column because they provide the fastest regeneration method. Desorption occurs at atmospheric pressure or vacuum pressure, resulting in a pressure swing from high pressure during adsorption to low pressure during desorption.

[0088] The overall efficiency of a plant is described by plant product purity, product recovery and bed size factor (BSF). The selectivity of the adsorbent for the chemical primarily determines the possible purity. Product recovery is a measure of the amount of the desired component in the high pressure product stream compared to the feed stream.

[0089] There is a trade-off between recovery and purity; that is, high purity generally results in lower recovery. The maximum potential recovery is determined by balancing the solids affinity of the heavy components against the light components. Recovery determines the energy efficiency of the process because it determines how much high pressure feed can be used based on the product rate. The overall design of the column, as well as the control philosophy and cycle time of the unit, will determine the BSF.

[0090] The device of the present invention uses a pressure swing adsorption (PSA) process in combination with zeolites to achieve oxygen concentration levels suitable for various uses, including medical uses. Figures 2A-2D As shown, the device of the present invention adopts a double column system design with staged production and regeneration processes. These steps include:

[0091] ·Adsorption (adsorption)- Figure 2A

[0092] ·Oxygen production (pressurized) Figure 2B

[0093] ·Exhaust (anti-purge)- Figure 2C ;as well as

[0094] ·Purge (desorption)- Figure 2D

[0095]

[0096]

[0097]

[0098] exist Figure 2A In , compressed air is fed into zeolite bed A. Nitrogen and argon molecules are confined in zeolite bed A, while oxygen is allowed to flow through zeolite bed A. Figure 2B In the process, the zeolite in zeolite bed A is saturated with nitrogen and argon molecules. Then, the compressed gas stream enters zeolite bed B. Figure 2C In the process, the zeolite in zeolite bed B absorbs nitrogen and argon molecules. Zeolite bed A is depressurized, thereby removing argon and nitrogen molecules from the system, e.g. Figure 2C and releases it into the atmosphere. Figure 2D The process starts over again. Compressed air is again fed into zeolite bed A, depressurizing zeolite bed B, thereby releasing the argon and nitrogen molecules in zeolite bed B from the system and into the atmosphere.

[0099] like Figures 2A-2D As shown, the sequence between each stage is critical to the success of the oxygen generator unit PSA to create continuous oxygen production. Between each stage, the zeolite can only produce a limited amount of oxygen at a time before it becomes saturated and exhausted. By being able to optimize and sequence the PSA flow, we are able to refresh and regenerate the zeolite for continuous use of the zeolite.

[0100] Device design

[0101] exist Figure 3-5 In the present invention, an exemplary device according to the present invention is provided. The technology package implemented in the device of the present invention is specifically designed to reduce size and increase modularity between components. The top and bottom manifolds, such as Figure 3 and Figure 4 The top of the manifold and Figure 3 and Figure 5 The bottom of the manifold in the tank is integrated with columns 1 and 2 via solenoid valves located at both ends of columns 1 and 2. A compressor (not shown) capable of delivering free-flow air at about 5 liters per minute (LPM) to about 15 liters per minute (LPM) can be used. In one embodiment, the compressor is capable of delivering free-flow air at about 6 LPM to about 12 LPM. The compressor can produce a pressure between about 1 bar and about 5 bar, or preferably between about 1.6 bar (about 14 psi) and about 2 bar (about 28 psi). In another embodiment, the compressor can produce a pressure of about 1.4 bar (about 20 psi) and can deliver free-flow air at about 1.4 LPM to about 3.3 LPM. In some embodiments, the compressor is connected to the rest of the manifold design by plastic tubing, pushing air into the container / column, for example Figure 3-5 Column 1 and column 2 in the column, thereby achieving PSA exchange.

[0102] The container / column design contains many unique attributes and is a custom container / column used to hold the zeolite. The design of the column (zeolite housing) must follow several key points to work properly. First, the column, e.g. Figure 3-5 Columns 1 and 2 in the zeolite pump need to have a sealed structure that can achieve or exceed the required pressure. The columns must also reduce airflow resistance and have an unobstructed airflow path. In addition, the columns need a way to allow air to pass through under pressure and keep the zeolite inside. Finally, the zeolite needs to be compressed and kept compressed to reduce movement and vibration of the zeolite.

[0103] First, for ease of manufacturing, the sealing structure can be made of aluminum and can be combined with an O-ring (e.g. Fig.12 This not only improves oxygen production results, but also keeps the zeolite inside the column from absorbing nitrogen from the surrounding air when not in use.

[0104] Reducing the resistance to airflow into and out of the column has proven to be important in achieving higher levels of oxygen production. Figure 6B , 6CAs shown, the caps closing off the ends of columns 1 and 2 feature a tapered flow path design to help direct air in and out of columns 1 and 2. Changing the flow path in this way helps reduce column cycle times and heat in the mechanical components. During development, we noticed that heat directly impacted oxygen production, reducing our efficiency with each cycle.

[0105] In addition, sintered glass filter disks (e.g., Fig.12 and Fig.14 The zeolites are filtered from the compressed air by sintered glass filter disks (such as sintered glass filter disks in the column) because their rigidity and porous characteristics are well suited for the application. Filtration has a variety of uses, including cleaning ambient air, preventing large microorganisms from entering the system and contaminating the purity of the oxygen, and preventing moisture from entering the column and permeating the zeolite, thereby affecting the performance of the PSA system. In order to maximize the effectiveness of the zeolite, the air needs to be as dry as possible. The sintered glass filter disk can also prevent the zeolite from escaping from the column. The device may include one or more filters. In one embodiment, the device may include a filter before the air enters the compressor. Silica gel can be used as a filter. In addition, the device may include another filter before the air enters the column, such as a sintered glass disk filter disposed within the column.

[0106] Additionally, compression of the zeolite in the column is necessary. Alternative designs for the filtration system may include dense foam open cells or rubber durometers. Dense foam may be a viable alternative to the filter and wave spring. For example, the rubber durometer may have a Shore hardness of 30A to 40A. By not providing the zeolite with room to escape the fast-moving air around it, the zeolite is forced to behave in the manner it is intended. For example, Fig.12 and Fig.14 As shown, the column is designed in such a way that a wave spring is inserted between the bottom of the cover and the above-mentioned sintered glass filter disk. When the cover is screwed off, the spring is compressed, forcing the sintered glass disk to push down on the zeolite below.

[0107] The column containing the zeolite can be customized with a single aluminum block through a computer numerical control (CNC) program. For mass production, the design of the column can use the latest engineering thermoplastics (e.g., polycarbonate / ABS), and the column can form a vacuum. The column can be formed in one go, saving space, and can have a common wall with two adsorbent columns. The device requires relatively low pressure and temperature, so engineered thermoplastic materials can be used. All devices currently on the market use machined or rolled aluminum. In addition, the column can include a unique manifold system at the top of the column to improve the overall space efficiency of the design. The column design can be modular and can allow additional capacity of zeolite to be loaded in the form of column cores when needed during peak exercise (just like loading additional batteries), thereby allowing the device size to be flexibly adjusted according to the user's specific activities. In addition, the column design can include an integrated double column with a common wall, i.e., two pressure columns in one total column assembly. The double column design can be made of extruded thermoplastic material and can reduce the overall space required for the overall assembly.

[0108] In some embodiments, the shape of the pillars may vary. For example, the shape of the pillars may be cylindrical, rectangular, and / or triangular.

[0109] In some embodiments, the top and bottom manifolds can be molded from aluminum. In other embodiments, various components of the device can be manufactured by casting with a finishing process, metal 3D printing with a finishing process, or wax or plastic 3D printing for casting. For example, the column can be manufactured by 3D printing. In other aspects, the device can be cast using aluminum to efficiently create finer details of the device.

[0110] The PSA process uses a column filled with adsorbent, where the feed mixture is introduced at one end of the column and the product is discharged from the other end. The feed gas concentration changes over time in the column, forming a concentration wave in the column as the adsorbate moves from the liquid phase into the adsorbed phase.

[0111] PSA uses one or more columns filled with an adsorbent (e.g., LiLSX zeolite, 5A zeolite, etc.) that preferentially adsorbs one type of gas molecule that is not in the gas mixture passing through the column. This usually occurs at a certain atmospheric pressure until the gas saturates the column with more strongly adsorbed gas molecules. Desorption of the column is critical to the efficiency of the process and is a step that is improved to increase the degree of regeneration to maximize the removal of heavy components and improve process efficiency.

[0112] exist Figure 4 and Figure 5In the figure, an exemplary top manifold and an exemplary bottom manifold according to an embodiment of the present invention are provided respectively. The manifold design of the device may include an internal pipe network, especially an internal pipe network machined and cut at specific points where micro-solenoid valves are located. The solenoid valve is an electromechanically operated valve, which is controlled by an electric current passing through the solenoid valve to open or close the flow in the case of a dual-port valve. This allows air to flow between each container / column without the need for additional pipes. In one embodiment, the solenoid valve can be controlled by an Arduino board, which will be described in further detail below. The Arduino board can control the opening and closing sequence of the solenoid valves in the device through programming. In other embodiments, the solenoid valve can be controlled by other hardware or software programs, including small board computers such as Raspberry Pi.

[0113] Additionally, the manifolds are designed in a way that provides minimal pressure loss to the system, and as we are still experimenting with designing these manifolds, their redundant design is able to reduce / change the orifice size. This feature helps us fine-tune the system output, exhaust, and flow to improve efficiency. The diameter of the holes on the top manifold and the bottom manifold may be different. In some embodiments, the diameter of the holes on the top manifold is approximately 3mm and the diameter of the holes on the bottom manifold is approximately 1.5mm. In other aspects, the ratio of the diameter of the holes on the top manifold to the diameter of the holes on the bottom manifold is approximately 2:1. In other aspects, the diameter ratio of the holes can be adjusted to reduce the risk of pressure drop and achieve better breathing throughout the device.

[0114] Manifolds can be made from aluminum due to its light weight and ease of fabrication. O-rings can be added to help seal the holes more reliably for a leak-free test bench. A one-way shutoff valve designed for faucets, called a check valve, can be inserted into the system to help prevent backward flow in the system. Additionally, O-rings can be inserted in combination with check valves, especially in manifolds, to ensure a secure seal.

[0115] In addition to integrating the manifold design with the column, dry and oil-free air must be available before the ambient air enters the vessel / column. Therefore, an integrally designed oil-free compressor design can be used. A compressor that does not require oil for lubrication and sealing is advantageous because it does not introduce any additional contaminants to the zeolite media, which would otherwise contaminate and reduce zeolite media adsorption and reduce the overall operating efficiency of the unit.

[0116] A predetermined amount of alumina zeolite is layered on top of the LiLSX zeolite to remove any moisture from the incoming ambient air. The predetermined amount of activated alumina zeolite can be determined by the following formula:

[0117]

[0118] Moisture in the ambient air has two effects, one is to reduce overall compressor efficiency, and the other is to contaminate the zeolite itself. Zeolites work most efficiently when clean air is passed over them. This "recipe" is designed to sacrificially remove water vapor from the air. For example, an oxygen concentrator may use an activated alumina composition to remove water molecules from the air before it reaches the zeolite. Otherwise, the water molecules may be adsorbed by the zeolite instead of the nitrogen, affecting the zeolite performance.

[0119] exist Fig.10 In a continuous oxygen environment, oxygen is produced continuously and the main function of the oxygen buffer is to provide oxygen during these downdraft peaks.

[0120] Due to technical limitations at the time of development, current POC devices are unable to provide continuous flow. Fig.11A As shown, current POCs have a fixed pulse flow to reduce size and increase battery life. This pulse flow uses sensors to sense changes in the device's oxygen output to deliver oxygen every time the patient breathes. If the breathing rate increases, the machine will generate an alarm. Unfortunately, depending on the sensitivity of the sensor, this means that the device may not output oxygen. In addition, the oxygen output is a linear set amount, which means there is a high possibility of over-dosing and / or under-dosing of oxygen.

[0121] The device of the present invention is newly developed from the perspective of the user and the doctor. The device can use its adaptive algorithm in the background to provide an accurate measurement of the user's activity level and output a corrected amount of oxygen. Fig. 11B As shown, the device can switch between pulsed flow and continuous flow on demand through input from an adaptive algorithm or manual input from the user. This is an adaptive model, not a reactive one. The device will change based on the user's physiology without manual input.

[0122] exist Fig.12 , an exemplary column design for an apparatus according to the present invention is provided. The length / diameter ratio is very important to the overall operating efficiency of the apparatus. In some embodiments, the diameter of the tube can be small and the length of the column can be long. This can maximize the contact surface area of ​​the zeolite to adsorb ambient air without causing significant pressure losses over the length of the column. Therefore, this can maximize the overall efficiency of the adsorbent media and eliminate any dead space. In other embodiments, the diameter of the tube can be larger and the length of the column can be shorter.

[0123] Each column can have an equal or equivalent amount of zeolite to maintain consistent gas flow throughout the columns and the PSA system to operate efficiently. If the two columns are not uniformly weighted (in grams), the PSA system will immediately experience a pressure drop because the gas flow between the two columns will be different, the circulation will be different, and the oxygen output will be significantly reduced.

[0124] The ratio of diameter to length is about 1:6, thus equating to a diameter of about 26 mm and a length of about 178 mm. According to the 1:6 ratio, a total weight of about 55 grams of zeolite is used per column. However, in some embodiments, each column may contain about 20 grams to about 80 grams of zeolite.

[0125] Radial Flow / Path

[0126] Conventional PSA typically has an axial flow configuration characterized by a bed length to bed diameter ratio of L / D>1 for vertical and L / D<1 for horizontal packed beds, respectively. Changing the packed column configuration to a radial flow geometry provides comparable performance to an axial bed, with the added advantages of large cross-sectional area, low pressure drop, and ease of expansion. Unlike the conventional axial flow configuration, the radial design enables a radial flow configuration in which air passes through the zeolite bed in a radial flow direction.

[0127] For example, radial designs increase interstitial flow velocity toward the center and sharpen the concentration wavefront, which promotes deeper feed penetration and leads to higher adsorbent utilization. In addition, with a radial design, the purge gas flows radially from the inner cylinder to the outer cylinder. The outer cylinder promotes decompression and desorption at low pressure. In addition, for the same feed pressure and the same adsorbent amount, the separation performance of radial flow PSA is better than that of axial flow PSA because the particle size used is smaller. Due to the large cross-sectional area for reducing the pressure drop, particles as small as a few μm can be used directly. Smaller particle size promotes faster adsorption reaction rates and achieves fast PSA. In addition, a thicker radial bed is better at reducing pressure drop because it provides a larger cross-sectional flow area, while a flat radial bed is better at higher heat transfer rates because it provides a larger flat surface area. These two features are important for a radial bed because it can be used to handle large flow rates that produce high pressure drop and thermal excursion problems. In addition, the zeolite filled in the radial bed can be exposed to a larger amount of air, thereby reducing the pressure drop and increasing the utilization of the zeolite in the same or similar volume space as the conventional radial flow configuration. The radial design also reduces the total amount of zeolite (grams) needed to generate oxygen because it increases the utilization of the zeolite. The radial design can reduce the amount of air required to operate the entire system, thereby reducing compressor requirements, battery weight, and the overall size of the POC.

[0128] Cap / Funnel Design

[0129]

[0130] Fig.13 The conical funnel is shown in the figure above. As shown, the conical funnel is at the top and the blue arrows show the compressed ambient air entering and leaving the container. The red arrows show the flow of compressed ambient air at the interface of the cover and the packed zeolite. A wave spring is used to press the sintered glass disk against the packed zeolite.

[0131] The device of the present invention utilizes a custom cap design that incorporates a spring-loaded mixing conical funnel. Using a flat spring saves space without sacrificing the compressive strength of the spring. The cap has a conical funnel integrated into the cover design to direct the flow into and out of the column. This minimizes short-circuiting in the zeolite column and directs the flow evenly onto the loading surface of the column.

[0132] During PSA operation, the zeolite expands and contracts depending on the stage of operation. Maintaining a steady flow can minimize any fluidization of the zeolite bed. Fig.14 As shown, the design of the device of the present invention includes a wave spring with a sintered glass disk to hold the media under variable compression (via the spring) so that the compressive force on the zeolite media is approximately equal to the compressive force holding the packing and minimizing any fluidization of the media bed. The wave spring can be placed between the sintered glass disk and the column cover to form a cavity that allows the spring to compress and contract, and the cavity does not contain zeolite. The wave spring allows the sintered glass disk to move up and down during the compression and decompression of the column, thereby being able to compress the zeolite for a period of time while the zeolite vibrates to the most efficient compression state. The wave spring and sintered glass disk work together to minimize the gaps between the zeolites, thereby allowing air to move through a more efficient path in the column and preventing the zeolite from moving out as air does.

[0133] The sintered glass disc is held in place by a plastic structure that also acts to hold the wave spring. The sintered glass disc is a microporous glass that allows the ambient air to be filtered to its nanometer level, preventing any zeolite from leaving the column. A wave spring is used because it requires a shorter stroke over the longitudinal length of the spring to obtain equal compressive strength compared to a helical compression type spring. O-rings are used for an airtight design.

[0134] A sintered glass disk can be used as a separator and filter paper at the top of the vessel / column where the wave spring is placed, as well as at the bottom of the column.

[0135] This unique combination of sintered glass disk and wave spring provides the following benefits:

[0136] a) Cut a precise opening at the cover interface to match the outer diameter of the wave spring to ensure the spring enters the cover of the device

[0137] b) A wave spring assembly is designed at the zeolite interface, allowing the spring and sintered glass media to move up and down to ensure uniform compression of the zeolite during all stages of the adsorption PSA process.

[0138] By using these techniques, the devices of the present invention are able to reduce the size of the overall device by utilizing micro-millimeter spaces to maximize functional output and minimize the size of the device.

[0139] exist Fig.15 In the present invention, an exemplary manifold monoblock design of a device according to the present invention is provided. The manifold monoblock design of the device is a single structural design. This unique combination allows for the use of a lighter and more rigid frame, thereby improving durability and reducing the number of required parts. In addition, a unique design of the device is the internal tube set integrated within the monoblock structure. At each outlet of the device manifold design, there is a 2 / 2-way electronic solenoid valve connected to a different tube set that pushes "clean" air from column 1 to column 2. The valve mechanically restricts the airflow between the inlet and outlet. However, when the solenoid valve is energized with an electric current, the solenoid valve magnetizes and lifts open the valve, allowing air to flow from the inlet to the outlet. This minimizes the external surface area and significantly reduces the number of components required to connect each valve together.

[0140] In order to deliver pure oxygen to the user, the device may include an output or oxygen port that allows the patient to connect the output of the device to a nasal cannula, facial mask, or other equivalent for inhalation of oxygen.

[0141] Electronic Circuits

[0142] Electrical and electronic design is critical to the automation of PSA systems as electricity is converted into energy to separate the air. Fig.16 , an overview of an exemplary electronic circuit is shown.

[0143] An electronic platform (e.g. Arduino board) can be programmed to control the valves in a 4-stage PSA sequence, such as Fig.17 The 4-level PSA sequence is also shown in the table below.

[0144]

[0145] Each stage can be a sequence, and the time of each stage can be as follows:

[0146] Stage 1: 8.0 seconds

[0147] Stage 2: 0.1 seconds

[0148] Stage 3: 8.0 seconds

[0149] Stage 4: 0.1 seconds

[0150] The timing of each stage can be adjusted to change the amount of oxygen delivered to the user. In other embodiments, the timing within each stage can be further adjusted to increase or decrease the cycle time for faster PSA operation. In turn, adjusting the internal cycle time can affect the speed at which the device starts.

[0151] The amount of oxygen delivered to the user may depend on the size of the column. For example, the amount of oxygen delivered may depend on the length and diameter of the column, the weight ratio, and how the ambient air moves within the column. Thus, the column may be "axial" in design, meaning that the air can only move vertically up and down within the column. In this way, the device may only output a predetermined amount of oxygen to the user. For example, to increase the amount of oxygen produced, it may be necessary to increase the amount of zeolite used.

[0152] In other embodiments, the column can be "radial" in design, meaning that air can move vertically and / or horizontally along the column, up and down, and side to side. In this way, the same amount of ambient air, if not a smaller amount of ambient air, can pass through the column, increasing contact with the zeolites in the zeolite bed. This can significantly increase the amount of oxygen delivered to the user with smaller dimensions (i.e., column length, diameter, and weight ratio).

[0153] Adaptive Algorithm

[0154] A proportional-integral-derivative (PID) controller can be used for precise and optimal control. The overall controlled variable is the device's output in LPM of O2, which is controlled by varying the device's flow rate via a variable speed DC drive brushless motor. The speed of the motor may be varied to match the desired oxygen output. The variable motor speed may be defined by the primary variable, SpO2, and adjusted by secondary variables such as heartbeat, respiratory rate, and / or flow rate.

[0155] Other feedback mechanisms are certain alarms (high, low, etc.) to detect certain conditions and trigger certain actions.

[0156] Alerts are usually:

[0157] High flow rate

[0158] Low flow

[0159] ·high pressure

[0160] Low pressure

[0161] High O2 concentration

[0162] Low O2 concentration

[0163] Operating hours

[0164] In some aspects, the alarm can be an audible alarm that alerts nearby people to help the user by triggering the alarm. In other aspects, the alarm can be a visual alarm. For example, the device can include an LCD or OLED display configured to display visual indications. The display can also display information on a preset selected by the user. The display can further assist in troubleshooting the device.

[0165] The unit's adaptive algorithm takes digital data from multiple inputs and adjusts to meet oxygen demand.

[0166] The apparatus of the present invention may include sensors for collecting real-time feeds of patient data regarding physiological parameters, including but not limited to respiratory volume, CO2 concentration in exhaled air, SpO2-O2 blood saturation, heart rate, pulse rate, average number of breaths per minute, inspiratory pressure, expiratory pressure, or breath sounds.

[0167] The parameters measured above can be analyzed by the device, and the data can be applied with an adaptive algorithm to identify the patient's real-time health state. In this health state, the device can be able to predict and adapt to changes in the patient's activities. As a result, the device's adaptive algorithm becomes "smarter" and "adaptive," tailored to the individual user. The accuracy of each measurement can be based on the ability of a third party to obtain regulatory approval (such as FDA approval), thereby determining the accuracy of the device's adaptive algorithm. The doctor can further pre-set the device's adaptive algorithm within the minimum and maximum capabilities, while the patient can still determine whether they need adaptive functionality. The device can be used in a wide range of markets, including but not limited to chronic obstructive pulmonary disease (COPD), asthma, pneumonia, heart failure, and chronic bronchitis.

[0168] Blood oxygen saturation (SpO2)

[0169] Blood oxygen saturation is a measurement of the percentage of a patient's circulating hemoglobin that is bound to oxygen. Pulse oximeters are commonly used to determine noninvasive SpO2 and provide continuous monitoring of oxygenation status. Pulse oximeters can serve as a useful guide to measure desaturation (low blood oxygen) that may occur during exercise, such as a drop of at least 4% to less than 90%. This would be a major indicator of hypoxia and indicate that the patient needs to increase oxygen production.

[0170] Healthy people should have an average SpO2 of 94% to 99%. For patients with mild respiratory diseases SpO2 should generally be 90% to 94%. Normally, more than 89% of the body's red blood cells should carry oxygen. Blood oxygen saturation of at least 89% keeps body cells healthy, but if low oxygen levels occur frequently, body cells may become stressed or damaged. Adjusting the oxygen flow within the range is designed to maintain SpO2 within the target range predetermined by the doctor.

[0171] As pulse oximeters have become more readily available over the past few years, it is common knowledge that these types of technologies will be used in the next generation of wearables and smartwatches (such as the Apple Watch) that are pending FDA approval. To operate an adaptive device, the device's adaptive algorithm relies on a third party SpO2 as the primary control variable for its operation. If the SpO2 is high or normal, the device will adjust itself to save power, if the SpO2 is low then it is detected, which will be a key indicator of hypoxia and indicate to the user that there is an increased need for oxygen production.

[0172] Respiration rate (BPM)

[0173] Respiratory rate is the number of times a person breathes per minute. In the device of the present invention, the respiratory rate will be measured by the increase / decrease of positive / negative pressure between the oxygen tube and the oxygen outlet hole. The increase / decrease of the positive / negative pressure signal is converted into a digital number and compared with time to obtain the "number of breaths per minute".

[0174] The normal respiratory rate for an adult at rest is 12 to 16 breaths per minute. During rest, an adult's respiratory rate is considered abnormal if it is less than 12 breaths / minute or more than 20 breaths / minute. Respiratory rate, body temperature, blood pressure, and pulse are the four main vital signs of the human body.

[0175] Respiratory rate is a secondary measure of the user's health and activity level. Abnormal respiratory rate is a predictor of potentially serious clinical events. Ventilation is driven by both the arterial pressure of oxygen (PaO2) and the arterial partial pressure of carbon dioxide (PaCO2), with PaCO2 being the most important driver. The body attempts to correct hypoxemia (low oxygen concentration in the blood) and hypercapnia (carbon dioxide retention in the blood) by increasing tidal volume (the amount of air that enters the lungs during normal inhalation) and respiratory rate. Therefore, these conditions can be detected by measuring respiratory rate.

[0176] Higher respiration rates can indicate higher activity levels and would be a useful signal for the device to increase or decrease oxygen delivery. Directly measuring respiration rate is challenging, and our device uses a surrogate pressure sensing transmitter on the device, at the outlet of the oxygen output, to detect when the user is breathing oxygen.

[0177] Tailoring oxygen to the patient's needs is not only desirable but necessary for effective outcomes.

[0178] Therefore, oxygen flow adjustment should meet multiple goals, including but not limited to minimizing desaturation episodes, avoiding excessive oxygen administration, and tailoring oxygen flow to the patient's needs.

[0179] Respiration rate can be used in the device's adaptive algorithms as a secondary measure of the user's health and activity level. Higher respiration rates may indicate higher activity levels, which would be a useful signal for the device to increase or decrease oxygen delivery. Directly measuring respiration rate is challenging, our device uses a surrogate pressure sensing transmitter on the device board at the outlet of the O2 output to detect when the user is breathing oxygen.

[0180] Pulse rate

[0181] The pulse is a direct measurement of heart rate. A normal adult resting pulse is between 60-100 beats per minute. Pulse oximeters can also estimate the percentage of total hemoglobin saturated with oxygen based on red and infrared light passing through the vascular bed using light emitting diodes (LEDs) and photodetectors. However, relying solely on pulse oximeters to regulate oxygen delivery may compromise patient safety.

[0182] Pulse oximeters can only report saturation levels. To be most effective, they must be used in conjunction with monitoring the patient's respiratory rate.

[0183] In the device’s adaptive algorithm, pulse rate can be a surrogate measurement of the user’s overall health and can also determine if the user is active. For example, a higher pulse rate indicates a higher activity level, and if a higher respiration rate and SpO2 are detected at the same time, this is also a key indicator for the device to increase oxygen output to meet the user’s oxygen needs.

[0184] A flow sensor is installed on the oxygen concentration device to measure the purity of the oxygen produced. The flow sensor provides feedback to the device indicating that the correct amount of product is being provided to the user. Any deviation from the expected value can trigger an alarm or fault, prompting the user to take action.

[0185] The oxygen sensor is the primary sensor that monitors the purity of oxygen production. This device is important to verify that the required oxygen concentration is being correctly provided to the user. If the value is too high or too low, the device can issue an alarm / fault, prompting the user to take action.

[0186] Adaptive oxygen titration

[0187] Oxygen therapy is life-saving, especially for patients with chronic obstructive pulmonary disease (COPD), and is a mainstay of any acute COPD treatment strategy. Oxygen should be considered a medication to be prescribed and provided for specific indications, with documented target oxygen ranges and regular monitoring of patient response.

[0188] Oxygen therapy is considered a benign medicine. Since 1949, the need to accurately adjust oxygen delivery and avoid the risks of hyperoxia and the triggers of hypercapnia has been emphasized. Recent clinical data suggest that excess oxygen may not be entirely beneficial to the human body. For example, users who inhale excessive amounts of oxygen may cause an increase in carbon dioxide levels, potentially leading to carbon dioxide poisoning. For patients with COPD, excess oxygen may have the opposite adverse effect, where the patient does not exhale enough to relieve carbon dioxide accumulation, but instead maintains carbon dioxide accumulation, leaving their lungs in worse shape than before oxygen therapy. During daily activities, a decrease in arterial oxygen saturation is also common in patients with COPD.

[0189] The oxygen flow rate is usually set to a fixed value for these patients and to a lower value for patients who cannot walk. The oxygen flow rate is adjusted within a range to maintain SpO2 within a predetermined target range that can be determined by the attending physician.

[0190] The ability to tailor oxygen therapy to the user's activity is highly desirable. Therefore, adjustments in oxygen flow should meet several goals, including but not limited to minimizing desaturation episodes, avoiding overdosing that may result in respiratory acidosis, and tailoring oxygen flow to the patient's needs, especially during activity.

[0191] The device's adaptive oxygen titration is based on three sets of available data, namely SpO2, respiration / breathing rate and pulse / heart rate. When more data is included, the adaptive algorithm that allows this to happen can be calibrated.

[0192] In one embodiment, to enable adaptive oxygen titration to function in the device of the present invention, the device can be sized for a maximum flow rate. Typically, the design capacity cannot be operated at its maximum limit. The device can be sized for 5LPM O2 output as 100% capacity. Typically at rest, it can operate at 3LPM, and at peak exercise, it can increase the speed of the device to increase the output of the compressor to add additional capacity. The volume of the adsorbent media and the size of the compressor can be set based on the maximum output. The battery size can be set based on average use. If the user needs to exercise, the battery sizing strategy can be 8 hours or average use time, or a shorter 4 hours peak use time. The battery may include a removable lithium ion battery with an external adapter for charging. The on-the-go operating time can be increased by replacing the battery.

[0193] In another embodiment, to enable adaptive oxygen titration to function throughout the device of the present invention, the modular design of the device can be set based on a maximum flow rate at an average flow rate, such as 3 LPM O2. Additional cartridges can be added to increase the capacity of the system to 5 LPM, thereby delivering additional oxygen at additional capacity. The compressor size can be set based on the larger flow rate. The battery size can be set based on average usage.

[0194] Key sizing capacity is LPM of O2 production, which is calibrated to clinical set points SpO2, BPM, heartbeat, etc.

[0195] Zeolite formula

[0196] To produce medical equivalent oxygen, the device may use a zeolite formulation consisting of 5A zeolite and LiLSX zeolite, or a zeolite formulation consisting of alumina zeolite and LiLSX zeolite. The addition of AgX zeolite is optional.

[0197] The World Health Organization (WHO) recommends oxygen concentrators as "an effective means of oxygen supply". In Canada, as many as 48 hospitals reported safe use of oxygen concentrators as the primary oxygen supply over a 10-year period, stating that oxygen concentrators are safe, reliable and cost-effective. The U.S. military has used 93% oxygen for many years and declared it acceptable in any clinical application.

[0198] Oxygen produced when used in oxygen cylinders or storage devices is typically 99% pure oxygen, a process known as vacuum rotary adsorption (VSA). As described elsewhere in the document, the device of the present invention will use pressure rotary adsorption (PSA) process technology to produce oxygen at 93% purity.

[0199] This raises the question of whether 93% oxygen is as suitable for patient care as 99% oxygen. According to clinical studies conducted in the United Kingdom, Canada, and the United States, clinical care remains the same regardless of whether the oxygen supply is 93% or 99% pure. One study examined the effectiveness of different oxygen delivery systems using 93% and 99% oxygen at 2L / min, 3L / min, and 4L / min. The results showed that inspired oxygen (FiO2) changed depending on the flow rate. However, there was no statistical difference in FiO2 between the different concentrations of oxygen at each flow rate.

[0200] The device of the present invention complies with the requirements of the International Organization for Standardization (ISO), which publishes the same regulations for 93% and 99% oxygen delivery systems. Neither the Canadian Standards Association (CSA) nor the US military distinguish between these systems.

[0201] The device of the present invention uses an adsorbent bed containing only zeolite molecular sieves. There are many varieties on the market (5AMG, MG3, 13X and OXYSIV-5), however, most oxygen concentrator manufacturers currently use Oxysiv 5, Oxysiv 7, KEG415, Oxysiv LiLSX, MS S 624, MS C 544 and AgLiLSX for pressure swing adsorption.

[0202] The rate of adsorption in zeolites depends on the extent to which rapid diffusion occurs within the zeolite pores. The diffusion rate is determined by rate characteristics including intrinsic properties of the adsorbent particles such as the structure, size and shape of the macropores. The rate of adsorption in zeolites is inversely proportional to the square of the particle radius and directly proportional to the macropore diffusivity and porosity.

[0203] Zeolites are hydrated aluminosilicates. Their structure is a three-dimensional framework consisting of AlO4 and SiO4 tetrahydrides coordinated by oxygen atoms. Zeolites are cation exchangers. Zeolites are used in a variety of applications, including adsorption / desorption of liquids and gases, energy storage, cation exchange, and catalysis.

[0204] In zeolites, cations are usually responsible for the selectivity for nitrogen. These zeolites preferentially adsorb nitrogen over oxygen (usually around 4:1), mainly due to the interaction between the cations of the zeolite and the quadrupole moment of the adsorbed gas. The quadrupole moment of nitrogen is about four times that of oxygen. Since these cations affect the adsorption capacity of zeolites in such a significant way, many attempts have been made to optimize the properties of zeolites by increasing the number of sites of the cations, creating zeolites with higher aluminum content; or synthesizing zeolites with different cation combinations.

[0205] It is proposed to add small amounts of silver to LiX-type zeolites (producing AgLiX-type zeolites) in order to improve the oxygen separation properties of the adsorbent from air. AgLiLSX-type zeolites, obtained by exchanging silver ions in LiLSX-type zeolites, exhibit high nitrogen adsorption capacity and high selectivity for nitrogen over oxygen at subatmospheric pressures. AgLiLSX-type zeolites (such as 40% silver-exchanged zeolites) can even exhibit selectivity for argon over oxygen, thereby allowing the production of high-purity oxygen (above 99%). This adsorbent can then be used directly for the production of high-purity oxygen (greater than 99.5% oxygen) in medical applications, allowing the production of PSA units for use in field hospitals or other places where this type of oxygen is needed immediately and in large quantities, or where liquid oxygen cylinders are insufficient or even impossible to meet the need.

[0206]

[0207] Zeolite composition and properties

[0208]

[0209]

[0210] The device of the present invention utilizes a unique zeolite formulation. The unique zeolite formulation may include an activated alumina and a LiLSX composition. As described above, the activated alumina composition may include at least one of Al2O3, Na2O, Fe2O3, TiO2, or SiO2. The LiLSX composition may include at least one of a zeolite, cubic, crystalline, synthetic, fiberless, mineral binder, or quartz (SiO2). Ideally, the smaller the zeolite particles, the better the performance, which can increase the contact area with the ambient air and achieve higher adsorption. Doing so can improve the oxygen productivity performance of the device, thereby reducing the bed size and, in turn, the overall POC physical capacity.

[0211] In some embodiments, the diameter of the zeolite may be from about 0.2 mm to about 1.0 mm. In a preferred embodiment, the diameter of the zeolite is about 0.4 mm.

[0212] However, the separation performance of zeolite cannot be infinitely improved by reducing the particle size. When the particles are too small (<0.4 mm), the mass transfer characteristics of the gas flowing through the bed will change. Due to the increase in the amount of oxygen required for reverse purge, the pressure drop across the bed increases and the oxygen recovery rate decreases.

[0213] According to an embodiment of the present invention, the zeolite composition may include an activated alumina composition and a LiLSX composition. The weight ratio of the activated alumina composition to the LiLSX composition may be in the range of about 0.2 to about 0.5. In some aspects, the LiLSX composition may include a plurality of first particles. The first particles may each have a size of about 0.4 mm and a mesh size of about 30x60. In other aspects, the activated alumina composition may include a plurality of second particles. The second particles may each have a size of about 0.5 mm and a mesh size of about 28x48.

[0214] In some embodiments, the particle size and mesh size used can be matched to the LiLSX composition and the activated alumina composition to allow the zeolite to have the same or similar adsorption rate at the same or similar pressure and flow rate. This can provide the best results to produce concentrated oxygen for the user.

[0215] Our main focus is to develop the best possible condition setup for the LiLSX material. Its particle size allows us to work within the parameters to reduce the overall POC physical capacity.

[0216] To measure the performance of our design against existing POCs on the market, we measured the output oxygen concentration and continuous oxygen flow rate (liters / minute). Typically, POCs produced on the market have oxygen concentrations ranging from 85-92% and continuous output flow rates of 0.33-3LPM. The pattern we noticed was that the continuous output flow rate was proportional to the size of the POC. The smallest POC weighing 1.5kg produced 0.33LPM continuously, while the 3LPM device weighed 9kg.

[0217] We found that most POCs on the market advertise their ability to produce pulse oxygen doses of more than 6 L / min. It is important to note that pulse doses deliver oxygen only when the patient breathes to simulate continuous flow. This specification cannot be used to measure the true performance of a POC because different vendors make different assumptions about the user's average number of breaths per minute and the volume of each pulse oxygen dose.

[0218] Fig.18 The weight specific loading of zeolite in the zeolite bed and the pressure drop measured across the zeolite bed are graphically compared. The apparatus of the present invention can operate in the range of about 1.4 bar (20 psi) to about 2 bar (29 psi). For example, at 1.4 bar, the apparatus can produce 85% oxygen purity, while at 2 bar, the apparatus can produce 91% oxygen purity.

[0219] Although the present invention is described herein with reference to illustrative embodiments of manifolds, columns, wave springs, zeolites, etc. for specific applications (e.g., providing concentrated oxygen to a user), it should be understood that the embodiments described herein are not limited thereto. Those of ordinary skill in the art and using the teachings provided herein will recognize that additional modifications, applications, embodiments, and alternatives of equivalents are within the scope of the disclosed embodiments. Therefore, the disclosed embodiments are not to be considered limited by the foregoing or following description.

[0220] The many features and advantages of the present invention are apparent from the detailed description, and therefore, the appended claims are intended to cover all such features and advantages of the present disclosure which fall within the true spirit and scope of the present disclosure. In addition, since numerous modifications and changes will readily occur to those skilled in the art, it is not desired to limit the present invention to the exact construction and operation shown and described, and therefore, all suitable modifications and equivalents fall within the scope of the present invention.

[0221] Furthermore, those skilled in the art will appreciate that the concepts upon which the present invention is based may readily be used as a basis for designing other structures, methods and systems for carrying out the several purposes of the present disclosure.Accordingly, the claims should not be considered limited by the foregoing description.

Claims

1. A portable oxygen concentrator, comprising: an input configured to receive an airflow; Input filter; a compressor configured to compress a gas flow; a first column comprising a first adsorbent bed; a second column adjacent to the first column and comprising a second adsorbent bed; a first output configured to release oxygen to a user; as well as a second output configured to release exhaust gas, wherein the first and second adsorbent beds comprise a plurality of zeolites including: an activated alumina composition; and A LiLSX composition wherein: The weight ratio of the activated alumina composition to the LiLSX composition is in the range of 0.2 to 0.5; The LiLSX composition includes a plurality of first particles, each first particle having a size of 0.4 mm and a mesh size of 30×60; and The activated alumina composition includes a plurality of second particles, each of the second particles having a size of 0.5 mm and a mesh size of 28×48, and Wherein the first and second columns are configured to direct air in a radial flow direction through the first and second columns and across the first and second adsorbent beds.

2. The portable oxygen concentrator of claim 1, further comprising: a top manifold at distal ends of the first and second columns; as well as a bottom manifold proximal to the first and second columns, Wherein the top and bottom manifolds include the first and second outputs and an internal ductwork configured to allow airflow therethrough.

3. The portable oxygen concentrator according to claim 2, wherein: The top and bottom manifolds further include a plurality of solenoid valves configured to control air flow.

4. The portable oxygen concentrator according to claim 2, wherein: The top and bottom manifolds are manufactured using at least one of a metal alloy, a plastic, or a resin by at least one of injection molding, CNC, or 3D printing.

5. The portable oxygen concentrator according to claim 2, wherein: The top and bottom manifolds further include a plurality of holes configured to control air flow rate.

6. The portable oxygen concentrator of claim 1, wherein: The first diameter of the input is greater than the second diameter of the second output.

7. The portable oxygen concentrator of claim 5, further comprising a plurality of check valves located on the top and bottom manifolds configured to seal the plurality of apertures.

8. The portable oxygen concentrator of claim 1, wherein: The first and second posts include at least one of aluminum or a thermoplastic material.

9. The portable oxygen concentrator of claim 1, wherein: The first and second pillars are cylindrical, rectangular or triangular.

10. The portable oxygen concentrator of claim 1, wherein: The first and second columns are 3D printed.

11. The portable oxygen concentrator of claim 1, wherein: The proximal ends of the first and second posts are connected to the first output; The distal ends of the first and second columns are connected to the compressor; and The first and second posts each include an O-ring coupled to at least one of the proximal end or the distal end.

12. The portable oxygen concentrator of claim 11, further comprising covers at the proximal and distal ends of the first and second columns, wherein the covers include a tapered airflow path.

13. The portable oxygen concentrator of claim 12, further comprising at least one sintered glass filter disk at the proximal end and the distal end of the first and second columns, wherein the at least one sintered glass filter disk is configured to filter the plurality of zeolites from compressed air.

14. The portable oxygen concentrator of claim 13, further comprising a wave spring positioned between the cover and the at least one sintered glass filter disk, wherein the wave spring is configured to compress the plurality of zeolites in the first and second columns.

15. The portable oxygen concentrator of claim 13, further comprising a dense foam material in the cover, wherein: The dense foam material is configured to compress the plurality of zeolites in the first and second columns.

16. The portable oxygen concentrator of claim 13, further comprising a rubber durometer located in the cover, wherein the rubber durometer is configured to compress the plurality of zeolites in the first and second columns.

17. The portable oxygen concentrator of claim 1, further comprising at least one sensor and a processor, wherein: The at least one sensor is configured to detect at least one physiological parameter of the user; and The processor is configured to adjust an amount of oxygen released to the user based on the detected at least one physiological parameter.

18. The portable oxygen concentrator of claim 17, wherein: The at least one sensor includes at least one of a pulse oximeter, a differential pressure sensor, an ECG, an EEG, a gyroscope, or an accelerometer.

19. The portable oxygen concentrator of claim 17, wherein: The at least one physiological parameter of the user includes at least one of respiratory volume, CO2 concentration in exhaled air, SpO2 concentration, heart rate, pulse rate, average number of breaths per minute, inspiratory pressure, expiratory pressure or breathing sounds.

20. The portable oxygen concentrator of claim 17, wherein: connecting a printed circuit board (PCB) to the compressor; and The at least one sensor is connected to the printed circuit board (PCB).

21. The portable oxygen concentrator of claim 17, wherein: The processor is further configured to generate an alarm when the detected at least one physiological parameter is above or below a predetermined threshold.

22. The portable oxygen concentrator of claim 1, wherein: The plurality of zeolites comprises at least one of LiLSX zeolite, LiAgX zeolite, AgX zeolite, NaX zeolite or CaA zeolite.

23. The portable oxygen concentrator of claim 1, wherein: The activated alumina composition comprises at least one of Al2O3, Na2O, Fe2O3, TiO2 or SiO2.

24. The portable oxygen concentrator of claim 1, wherein: The LiLSX composition comprises at least one of zeolite, cubic, crystalline, synthetic, fiber-free, mineral binder, or quartz (SiO2).

25. The portable oxygen concentrator of claim 1, wherein: When the second column is configured to release exhaust to the second output, the first column is configured to provide oxygen to the first output; and When the second column is configured to provide oxygen to the first output, the first column is configured to release exhaust gas to the second output.

26. The portable oxygen concentrator of claim 1, wherein: The ratio of the diameter to the length of the first and second columns is 1:

6.

27. The portable oxygen concentrator of claim 1, wherein: The first and second columns are configured to direct air in the radial flow direction to increase contact with the plurality of zeolites in the first and second adsorbent beds.

28. The portable oxygen concentrator of claim 1, wherein: The first and second columns each contained 20 to 80 grams of zeolite.

29. The portable oxygen concentrator of claim 1, wherein: The pressure within the first and second columns is maintained between 1 bar pressure and 5 bar pressure.

30. The portable oxygen concentrator of claim 29, wherein: The pressure within the first and second columns was maintained between 1.25 bar pressure and 2 bar pressure.

31. The portable oxygen concentrator of claim 17, further comprising a user interface configured to receive user input, wherein the processor is configured to adjust the amount of oxygen delivered to the user based on the user input.

32. The portable oxygen concentrator of claim 17, further comprising a wireless receiver configured to receive data from a remote device, wherein the processor is configured to adjust the amount of oxygen delivered to the user based on the received data.

33. The portable oxygen concentrator of claim 32, wherein: The remote device includes at least one of a computer, a smart phone, or a wearable device.

34. The portable oxygen concentrator of claim 1, further comprising a removable battery connected to the first and second posts.

35. A portable oxygen concentrator, the portable oxygen concentrator comprising: an input configured to receive an airflow; Input filter; a compressor configured to compress a gas flow; a first column comprising a first adsorbent bed; a second column adjacent to the first column and comprising a second adsorbent bed; a first output configured to release oxygen to a user; as well as a second output configured to release exhaust gas, wherein the first and second adsorbent beds comprise a plurality of zeolites including: an activated alumina composition; and A LiLSX composition wherein: The weight ratio of the activated alumina composition to the LiLSX composition is in the range of 0.2 to 0.5; The LiLSX composition includes a plurality of first particles, each first particle having a size of 0.4 mm and a mesh size of 30×60; and The activated alumina composition includes a plurality of second particles, each of the second particles having a size of 0.5 mm and a mesh size of 28×48.

Citation Information

Patent Citations

  • Oxygen concentrator

    CN101522246A

  • Portable oxygen concentration system

    CN1649646A

  • Oxygen concentrator apparatus and method

    US20090065007A1

  • Sieve bed

    US20120006199A1